연락처(단축번호):070-8262-1635
PubMed상의 PMID Number를 기재해주시면 더욱 빠른 서비스가 가능합니다.

Nat Rev Cancer. 2012 Jan 24;12(2):89-103. doi: 10.1038/nrc3205.
Targeting MET in cancer: rationale and progress.
PMID:22270953

Nat Rev Cancer. 2005 May;5(5):341-54.
ERBB receptors and cancer: the complexity of targeted inhibitors.
PMID:15864276

Nat Rev Endocrinol. 2011 Jan;7(1):11-24. doi: 10.1038/nrendo.2010.171. Epub 2010 Oct 19.
Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.
PMID:20956999

Cancer Res. 2010 Feb 1;70(3):1204-14. doi: 10.1158/0008-5472.CAN-09-3321. Epub 2010 Jan 26.
Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin.
PMID:20103628

Nat Rev Cancer. 2010 Feb;10(2):116-29. doi: 10.1038/nrc2780.
Fibroblast growth factor signalling: from development to cancer.
PMID:20094046




=====================================답변========================================
발송완료입니다.